Amgen, Inc. (AMGN)
333.96
+2.47
(+0.75%)
USD |
NASDAQ |
Dec 24, 16:00
Amgen Market Cap: 179.83B for Dec. 24, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 25.87B |
| Gilead Sciences, Inc. | 155.92B |
| Johnson & Johnson | 500.60B |
| Eli Lilly & Co. | 963.92B |
| Regeneron Pharmaceuticals, Inc. | 82.37B |
Market Cap Related Metrics
| PE Ratio | 25.82 |
| PS Ratio | 5.039 |
| PEG Ratio | 0.3934 |
| Price to Book Value | 18.70 |
| Price to Free Cash Flow | 15.67 |
| Price | 333.96 |
| Earnings Yield | 3.87% |
| PEGY Ratio | 0.377 |
| Operating PE Ratio | 17.64 |
| Normalized PE Ratio | 22.26 |